Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sarka Pavlova

Showing results (21-30 of 30) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 30 results.
International Journal of Molecular Sciences|February 15, 2022
The Absence of Retroelement Activity Is Characteristic for Childhood Acute Leukemias and Adult Acute Lymphoblastic LeukemiaShamil Urazbakhtin, Anastasia Smirnova, Anastasiya Volakhava, et al.
Blood|January 12, 2012
MicroRNA-650 expression is influenced by immunoglobulin gene rearrangement and affects the biology of chronic lymphocytic leukemiaMarek Mraz, Dasa Dolezalova, Karla Plevova, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 5, 2015
Autocrine Signaling by Wnt-5a Deregulates Chemotaxis of Leukemic Cells and Predicts Clinical Outcome in Chronic Lymphocytic LeukemiaPavlina Janovska, Lucie Poppova, Karla Plevova, et al.
British Journal of Haematology|September 22, 2016
Decreased WNT3 expression in chronic lymphocytic leukaemia is a hallmark of disease progression and identifies patients with worse prognosis in the subgroup with mutated IGHVLucie Poppova, Pavlina Janovska, Karla Plevova, et al.
Epigenetics|March 25, 2022
Memory B-cell like chronic lymphocytic leukaemia is associated with specific methylation profile of <i>WNT5A</i> promoter and undetectable expression of <i>WNT5A</i> geneLucie Poppova, Sarka Pavlova, Beatriz Gonzalez, et al.
Leukemia|May 16, 2024
ERIC recommendations for TP53 mutation analysis in chronic lymphocytic leukemia-2024 updateJitka Malcikova, Sarka Pavlova, Panagiotis Baliakas, et al.
Blood|May 4, 2021
Low-burden TP53 mutations in CLL: clinical impact and clonal evolution within the context of different treatment optionsJitka Malcikova, Sarka Pavlova, Barbara Kunt Vonkova, et al.
Blood|January 11, 2018
Casein kinase 1 is a therapeutic target in chronic lymphocytic leukemiaPavlina Janovska, Jan Verner, Jiri Kohoutek, et al.
Haematologica|August 2, 2014
MDM2 promotor polymorphism and disease characteristics in chronic lymphocytic leukemia: results of an individual patient data-based meta-analysisAxel Benner, Larry Mansouri, Davide Rossi, et al.
Hemasphere|January 22, 2025
Detection of clinically relevant variants in the <i>TP53</i> gene below 10% allelic frequency: A multicenter study by ERIC, the European Research Initiative on CLLSarka Pavlova, Jitka Malcikova, Lenka Radova, et al.
Pageof 3

Showing results (21-30 of 30) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 30 results.
International Journal of Molecular Sciences|February 15, 2022
The Absence of Retroelement Activity Is Characteristic for Childhood Acute Leukemias and Adult Acute Lymphoblastic LeukemiaShamil Urazbakhtin, Anastasia Smirnova, Anastasiya Volakhava, et al.
Blood|January 12, 2012
MicroRNA-650 expression is influenced by immunoglobulin gene rearrangement and affects the biology of chronic lymphocytic leukemiaMarek Mraz, Dasa Dolezalova, Karla Plevova, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 5, 2015
Autocrine Signaling by Wnt-5a Deregulates Chemotaxis of Leukemic Cells and Predicts Clinical Outcome in Chronic Lymphocytic LeukemiaPavlina Janovska, Lucie Poppova, Karla Plevova, et al.
British Journal of Haematology|September 22, 2016
Decreased WNT3 expression in chronic lymphocytic leukaemia is a hallmark of disease progression and identifies patients with worse prognosis in the subgroup with mutated IGHVLucie Poppova, Pavlina Janovska, Karla Plevova, et al.
Epigenetics|March 25, 2022
Memory B-cell like chronic lymphocytic leukaemia is associated with specific methylation profile of <i>WNT5A</i> promoter and undetectable expression of <i>WNT5A</i> geneLucie Poppova, Sarka Pavlova, Beatriz Gonzalez, et al.
Leukemia|May 16, 2024
ERIC recommendations for TP53 mutation analysis in chronic lymphocytic leukemia-2024 updateJitka Malcikova, Sarka Pavlova, Panagiotis Baliakas, et al.
Blood|May 4, 2021
Low-burden TP53 mutations in CLL: clinical impact and clonal evolution within the context of different treatment optionsJitka Malcikova, Sarka Pavlova, Barbara Kunt Vonkova, et al.
Blood|January 11, 2018
Casein kinase 1 is a therapeutic target in chronic lymphocytic leukemiaPavlina Janovska, Jan Verner, Jiri Kohoutek, et al.
Haematologica|August 2, 2014
MDM2 promotor polymorphism and disease characteristics in chronic lymphocytic leukemia: results of an individual patient data-based meta-analysisAxel Benner, Larry Mansouri, Davide Rossi, et al.
Hemasphere|January 22, 2025
Detection of clinically relevant variants in the <i>TP53</i> gene below 10% allelic frequency: A multicenter study by ERIC, the European Research Initiative on CLLSarka Pavlova, Jitka Malcikova, Lenka Radova, et al.
Pageof 3